Shahla Shahbazi

Clinical development of human vaccine candidates against Shigella flexneri: a systematic review of clinical trials.

Shigella flexneri remains a leading cause of shigellosis, particularly in low- and middle-income countries, where it contributes substantially to childhood morbidity, mortality, and the growing burden of antimicrobial resistance. Despite decades of vaccine research, no licensed vaccine against S. flexneri is currently...